Kim M Keeling

7PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionImmunogenetics (incl. genetic immunology)Gene and molecular therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 21, 2024
Extended stop codon context predicts nonsense codon readthrough efficiency in human cells.

Kotchaphorn Mangkalaphiban, Lianwu Fu, Ming Du

|Apr 04, 2023
The synthetic aminoglycoside ELX-02 induces readthrough of G550X-CFTR producing superfunctional protein that can be further enhanced by CFTR modulators.

Jianguo Chen, Kari Thrasher, Lianwu Fu

|Mar 11, 2023
Triamterene Functions as an Effective Nonsense Suppression Agent for MPS I-H (Hurler Syndrome).

Amna Siddiqui, Halil Dundar, Jyoti Sharma

|Jul 20, 2022
Ataluren suppresses a premature termination codon in an MPS I-H mouse.

Dan Wang, Xiaojiao Xue, Gwen Gunn

|Jul 17, 2021
A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion.

Jyoti Sharma, Ming Du, Eric Wong

|Aug 02, 2020
A regulated NMD mouse model supports NMD inhibition as a viable therapeutic option to treat genetic diseases.

Josh Echols, Amna Siddiqui, Yanying Dai

Pageof 2

Frequent Collaborators

4 joint publications

David M Bedwell

3 joint publications

Steven M Rowe

2 joint publications

Kari Thrasher

1 joint publications

Jamie Wangen